Nicholas Company Inc. lessened its stake in shares of Lam Research Corporation (NASDAQ:LRCX – Free Report) by 27.4% during the 4th quarter, Holdings Channel reports. The fund owned 321,092 shares of the semiconductor company’s stock after selling 121,448 shares during the quarter. Nicholas Company Inc.’s holdings in Lam Research were worth $54,965,000 at the end of the most recent quarter.
Other institutional investors have also modified their holdings of the company. PMV Capital Advisers LLC purchased a new position in shares of Lam Research during the 4th quarter worth $25,000. Stance Capital LLC purchased a new position in shares of Lam Research during the 3rd quarter worth $26,000. Triumph Capital Management purchased a new position in shares of Lam Research during the 3rd quarter worth $27,000. Harbor Investment Advisory LLC raised its holdings in shares of Lam Research by 73.9% during the 4th quarter. Harbor Investment Advisory LLC now owns 240 shares of the semiconductor company’s stock worth $41,000 after acquiring an additional 102 shares during the period. Finally, WealthCollab LLC raised its holdings in shares of Lam Research by 29.3% during the 4th quarter. WealthCollab LLC now owns 243 shares of the semiconductor company’s stock worth $42,000 after acquiring an additional 55 shares during the period. Hedge funds and other institutional investors own 84.61% of the company’s stock.
Insider Transactions at Lam Research
In other news, CFO Douglas R. Bettinger sold 50,057 shares of the business’s stock in a transaction dated Wednesday, March 4th. The stock was sold at an average price of $224.03, for a total transaction of $11,214,269.71. Following the completion of the transaction, the chief financial officer directly owned 1,081,705 shares of the company’s stock, valued at approximately $242,334,371.15. The trade was a 4.42% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, SVP Neil J. Fernandes sold 18,170 shares of the business’s stock in a transaction dated Friday, May 1st. The stock was sold at an average price of $255.14, for a total value of $4,635,893.80. Following the transaction, the senior vice president directly owned 66,129 shares of the company’s stock, valued at approximately $16,872,153.06. This represents a 21.55% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last ninety days, insiders sold 120,066 shares of company stock valued at $27,953,242. 0.31% of the stock is currently owned by corporate insiders.
Analyst Upgrades and Downgrades
Check Out Our Latest Stock Report on Lam Research
Lam Research Stock Performance
NASDAQ LRCX opened at $294.05 on Monday. The company has a market cap of $367.73 billion, a P/E ratio of 55.48, a P/E/G ratio of 2.43 and a beta of 1.81. The company has a debt-to-equity ratio of 0.35, a current ratio of 2.54 and a quick ratio of 1.77. The stock has a 50-day moving average of $238.93 and a two-hundred day moving average of $204.97. Lam Research Corporation has a 1-year low of $74.65 and a 1-year high of $297.99.
Lam Research (NASDAQ:LRCX – Get Free Report) last released its earnings results on Wednesday, April 22nd. The semiconductor company reported $1.47 earnings per share for the quarter, beating the consensus estimate of $1.36 by $0.11. The company had revenue of $5.84 billion during the quarter, compared to the consensus estimate of $5.70 billion. Lam Research had a return on equity of 66.21% and a net margin of 30.94%.Lam Research’s revenue was up 23.8% compared to the same quarter last year. During the same period in the previous year, the company posted $1.04 EPS. Lam Research has set its Q4 2026 guidance at 1.500-1.800 EPS. As a group, analysts anticipate that Lam Research Corporation will post 5.67 EPS for the current year.
More Lam Research News
Here are the key news stories impacting Lam Research this week:
- Positive Sentiment: B. Riley raised its price target on Lam Research to $350 from $330 and kept a Buy rating, citing strong earnings and solid execution. Why Analysts Are Growing More Confident In Lam Research (LRCX)
- Positive Sentiment: Erste Group Bank lifted FY2027 EPS estimates for Lam Research to $7.88 from $7.74, suggesting analysts see better long-term earnings power. Lam Research stock page
- Positive Sentiment: Recent coverage highlights Lam Research as an AI-fab beneficiary with orders beating expectations, supporting the case for further upside after a sharp rally. Lam Research (LRCX) Is Up 19.5% After AI-Fab Orders Beat Expectations Has The Bull Case Changed?
- Neutral Sentiment: Some commentary notes the stock has already surged dramatically over the past year, which may raise overbought concerns even as Wall Street remains constructive. Lam Research Has Surged 300% in a Year. Wall Street Sees More Gains Still Ahead
- Neutral Sentiment: Investor articles argue the rally may still have room to run, but that view is speculative rather than a direct fundamental update. Why Lam Research Still Looks Like a Buy After a 300% Rally
About Lam Research
Lam Research Corporation (NASDAQ: LRCX) is a global supplier of wafer fabrication equipment and services to the semiconductor industry. Founded in 1980 by David K. Lam and headquartered in Fremont, California, the company develops and manufactures systems used in multiple stages of semiconductor device production, including thin film deposition, plasma etch, wafer cleaning and related process modules and automation.
Lam’s product portfolio covers core process technologies employed by logic and memory manufacturers, with equipment designed to support advanced-node patterning, 3D NAND and other emerging device architectures.
Featured Articles
- Five stocks we like better than Lam Research
- Beyond NVIDIA: Picks-and-Shovels AI Plays with Strong Momentum
- Quantum Earnings Season Is Ramping Up—What to Watch From 2 Major Players
- Flutter Sees Post-Earnings Boost as FanDuel Shows Signs of Recovery
- 3 Healthcare Stocks Set to Benefit From the One Big Beautiful Bill
Want to see what other hedge funds are holding LRCX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Lam Research Corporation (NASDAQ:LRCX – Free Report).
Receive News & Ratings for Lam Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lam Research and related companies with MarketBeat.com's FREE daily email newsletter.
